{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:14:34Z","timestamp":1773980074109,"version":"3.50.1"},"reference-count":62,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T00:00:00Z","timestamp":1702684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>In patients with early-stage or recurrent NSCLC who are unable to tolerate surgery, a benefit could derive only from a systemic therapy or another few forms of local therapy. A systematic review was performed to evaluate the feasibility and the effectiveness of radiotherapy combined with local ablative therapies in the treatment of primary and recurrent lung cancer in terms of toxicity profile and local control rate. Six studies featuring a total of 115 patients who met eligibility criteria and 119 lesions were included. Three studies evaluated lung cancer patients with a medically inoperable condition treated with image-guided local ablative therapies followed by radiotherapy: their local control rate (LC) ranged from 75% to 91.7% with only 15 patients (19.4%) reporting local recurrence after combined modality treatment. The other three studies provided a salvage option for patients with locally recurrent NSCLC after RT: the median follow-up period varied from 8.3 to 69.3 months with an LC rate ranging from 50% to 100%. The most common complications were radiation pneumonitis (9.5%) and pneumothorax (29.8%). The proposed intervention appears to be promising in terms of toxicity profile and local control rate. Further prospective studies are need to better delineate combining LTA-RT treatment benefits in this setting.<\/jats:p>","DOI":"10.3390\/cancers15245869","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T10:04:47Z","timestamp":1702893887000},"page":"5869","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Combination of Local Ablative Techniques with Radiotherapy for Primary and Recurrent Lung Cancer: A Systematic Review"],"prefix":"10.3390","volume":"15","author":[{"given":"Paolo","family":"Bonome","sequence":"first","affiliation":[{"name":"Radiation Oncology Unit, Responsible Research Hospital, 86100 Campobasso, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6676-1169","authenticated-orcid":false,"given":"Donato","family":"Pezzulla","sequence":"additional","affiliation":[{"name":"Radiation Oncology Unit, Responsible Research Hospital, 86100 Campobasso, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3507-7051","authenticated-orcid":false,"given":"Valentina","family":"Lancellotta","sequence":"additional","affiliation":[{"name":"Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, UOC Radioterapia Oncologica, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Rita","family":"Scrofani","sequence":"additional","affiliation":[{"name":"Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, UOC Radiologia d\u2019Urgenza ed Interventistica, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0529-201X","authenticated-orcid":false,"given":"Gabriella","family":"Macchia","sequence":"additional","affiliation":[{"name":"Radiation Oncology Unit, Responsible Research Hospital, 86100 Campobasso, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Rodolfino","sequence":"additional","affiliation":[{"name":"Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, UOC Radiologia Addomino-Pelvica, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2308-0982","authenticated-orcid":false,"given":"Luca","family":"Tagliaferri","sequence":"additional","affiliation":[{"name":"Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, UOC Radioterapia Oncologica, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5149-9831","authenticated-orcid":false,"given":"Gy\u00f6rgy","family":"Kov\u00e1cs","sequence":"additional","affiliation":[{"name":"Gemelli-INTERACTS, Universit\u00e0 Cattolica del Sacro Cuore, 20123 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1276-5070","authenticated-orcid":false,"given":"Francesco","family":"Deodato","sequence":"additional","affiliation":[{"name":"Radiation Oncology Unit, Responsible Research Hospital, 86100 Campobasso, Italy"},{"name":"Radiology Institute, Universit\u00e0 Cattolica del Sacro Cuore, 00135 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2791-481X","authenticated-orcid":false,"given":"Roberto","family":"Iezzi","sequence":"additional","affiliation":[{"name":"Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, UOC Radiologia d\u2019Urgenza ed Interventistica, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","first-page":"1623","article-title":"Non-small cell lung cancer: Epidemiology, screening, diagnosis, and treatment","volume":"94","author":"Duma","year":"2019","journal-title":"Themat. Rev. Neoplast. Hematol. Med. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cllc.2015.04.001","article-title":"Primary Treatment Options for High-Risk\/Medically Inoperable Early Stage NSCLC Patients","volume":"16","author":"Jones","year":"2015","journal-title":"Clin. Lung Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.21037\/tlcr-20-1185","article-title":"Alternative methods for local ablation\u2014Interventional pul-monology: A narrative review","volume":"10","author":"Olive","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2214\/ajr.174.1.1740057","article-title":"Percutaneous Radiofrequency Ablation of Malignancies in the Lung","volume":"174","author":"Dupuy","year":"2000","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ejrad.2009.07.034","article-title":"Radiofrequency, microwave and laser ablation of pulmonary neoplasms: Clinical studies and technical considerations\u2014Review article","volume":"77","author":"Thomas","year":"2011","journal-title":"Eur. J. Radiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.4103\/jcrt.jcrt_880_22","article-title":"Clinical practice guidelines on image-guided thermal ablation of primary and metastatic lung tumors (2022 edition)","volume":"18","author":"Ye","year":"2022","journal-title":"J. Cancer Res. Ther."},{"key":"ref_8","unstructured":"(2023, November 03). NCCN Clinical Practice Guidelines in Oncology. Non-Small Cell Lung Cancer Versions 5.2023. Available online: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1450."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.lungcan.2009.05.007","article-title":"Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial","volume":"68","author":"Ricardi","year":"2010","journal-title":"Lung Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1200\/OP.22.00475","article-title":"Stereotactic Body Radiotherapy for the Management of Early-Stage Non\u2013Small-Cell Lung Cancer: A Clinical Overview","volume":"19","author":"Buchberger","year":"2023","journal-title":"JCO Oncol. Pr."},{"key":"ref_12","first-page":"1957","article-title":"Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: Exploring mechanisms of interaction","volume":"9","author":"Wachsberger","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1055\/s-2004-828945","article-title":"Radiofrequency Ablation and Radiotherapy: Complementing Treatments for Solid Tumors","volume":"20","author":"DiPetrillo","year":"2003","journal-title":"Semin. Interv. Radiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2214\/ajr.183.2.1830361","article-title":"Radiofrequency Ablation of 40 Lung Neoplasms: Preliminary Results","volume":"183","author":"Gadaleta","year":"2004","journal-title":"Am. J. Roentgenol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijrobp.2021.04.020","article-title":"Long-Term Outcomes from a Phase 2 Trial of Radiofrequency Ablation Combined with External Beam Radiation Therapy for Patients With Inoperable Non-Small Cell Lung Cancer","volume":"111","author":"Steber","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/01.RVI.0000228373.58498.6E","article-title":"Percutaneous Image-guided Thermal Ablation and Radiation Therapy: Outcomes of Combined Treatment for 41 Patients with Inoperable Stage I\/II Non\u2013Small-Cell Lung Cancer","volume":"17","author":"Grieco","year":"2006","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1378\/chest.129.3.738","article-title":"Radiofrequency Ablation Followed by Conventional Radiotherapy for Medically Inoperable Stage I Non-small Cell Lung Cancer","volume":"129","author":"Dupuy","year":"2006","journal-title":"Chest"},{"key":"ref_18","unstructured":"(2018, May 11). Institute of Health Economics (2016) Case Series Studies Quality Appraisal Checklist. Available online: https:\/\/www.ihe.ca\/research-programs\/rmd\/cssqac\/cssqac-about."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Br. Med. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3109\/02656736.2015.1137640","article-title":"Percutaneous CT-guided thermal ablation as salvage therapy for recurrent non-small cell lung cancer after external beam radiotherapy: A retrospective study","volume":"32","author":"Cheng","year":"2016","journal-title":"Int. J. Hyperth."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e491","DOI":"10.1016\/j.ejrad.2010.09.042","article-title":"Image-guided tumor ablation for the treatment of recurrent non-small cell lung cancer within the radiation field","volume":"80","author":"Leung","year":"2011","journal-title":"Eur. J. Radiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e181390","DOI":"10.1001\/jamanetworkopen.2018.1390","article-title":"Association of Long-term Outcomes and Survival with Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer","volume":"1","author":"Brooks","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Zhang, X.-F., Lai, L., Zhou, H., Mo, Y.-J., Lu, X.-Q., Liu, M., Lu, Y.-X., and Hou, E.-C. (2022). Stereotactic body ra-diotherapy plus transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma patients with portal vein tumour thrombus: A meta analysis. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0268779"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1016\/j.clgc.2021.04.010","article-title":"Com-bining Stereotactic Body Radiotherapy and Microwave Ablation Appears Safe and Feasible for Renal Cell Carcinoma in an Early Series","volume":"19","author":"Blitzer","year":"2021","journal-title":"Clin. Genitourin Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1148\/radiol.2351040269","article-title":"Reduced Tumor Growth with Combined Radiofrequency Ablation and Radiation Therapy in a Rat Breast Tumor Model","volume":"235","author":"Horkan","year":"2005","journal-title":"Radiology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2214\/ajr.181.3.1810711","article-title":"Percutaneous radiofrequency ablation of pulmonary malig-nancies: Combined treatment with brachytherapy","volume":"181","author":"Jain","year":"2003","journal-title":"Am. J. Roentgenol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3109\/02656736.2015.1026413","article-title":"Development of a novel method to enhance the therapeutic effect on tumours by simultaneous action of radiation and heating","volume":"31","author":"Kosterev","year":"2015","journal-title":"Int. J. Hyperth."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"106046","DOI":"10.1016\/j.icheatmasstransfer.2022.106046","article-title":"Incorporating vascular-stasis based blood perfusion to evaluate the thermal signatures of cell-death using modified Arrhenius equation with regeneration of living tissues during nanoparticle-assisted thermal therapy","volume":"135","author":"Singh","year":"2022","journal-title":"Int. Commun. Heat Mass Transf."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Singh, M., Singh, T., and Soni, S. (2021). Pre-operative Assessment of Ablation Margins for Variable Blood Perfusion Metrics in a Magnetic Resonance Imaging Based Complex Breast Tumour Anatomy: Simulation Paradigms in Thermal Therapies. Comput. Methods Programs Biomed., 198.","DOI":"10.1016\/j.cmpb.2020.105781"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.diii.2015.04.007","article-title":"Ablative therapies: Advantages and disadvantages of radiofrequency, cryotherapy, microwave and electroporation methods, or how to choose the right method for an individual patient","volume":"96","author":"Seror","year":"2015","journal-title":"Diagn. Interv. Imaging"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1148\/radiol.2431060088","article-title":"Pulmonary Radiofrequency Ablation: Long-term Safety and Efficacy in 153 Patients","volume":"243","author":"Simon","year":"2007","journal-title":"Radiology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1765.e74","DOI":"10.1245\/s10434-008-9848-7","article-title":"A systematic review of radiofrequency ablation for lung tumours","volume":"15","author":"Zhu","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"621.e8","DOI":"10.1016\/S1470-2045(08)70155-4","article-title":"Response to radiofrequency ablation of pulmonary tumours: A prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study)","volume":"9","author":"Lencioni","year":"2008","journal-title":"Lancet Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Alzubaidi, S.J., Liou, H., Saini, G., Segaran, N., Kriegshauser, J.S., Naidu, S.G., Patel, I.J., and Oklu, R. (2021). Percutaneous Image-Guided Ablation of Lung Tumors. J. Clin. Med., 10.","DOI":"10.3390\/jcm10245783"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.crad.2017.01.005","article-title":"Lung ablation: Best practice\/results\/response assessment\/role alongside other ablative Therapies","volume":"72","author":"Tselikas","year":"2017","journal-title":"Clin. Radiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/jso.23701","article-title":"Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: Clinical evaluation of 47 cases","volume":"110","author":"Yang","year":"2014","journal-title":"J. Surg. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1080\/02656736.2018.1434901","article-title":"Comparison between microwave ablation and lobectomy for stage I non-small cell lung cancer: A propensity score analysis","volume":"34","author":"Yao","year":"2018","journal-title":"Int. J. Hyperth."},{"key":"ref_38","first-page":"659","article-title":"Usefulness of percutaneous microwave ablation for large non-small cell lung cancer: A preliminary report","volume":"18","author":"Pusceddu","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.diii.2019.07.008","article-title":"Percutaneous thermal ablation of primary and secondary lung tumors: Comparison between microwave and radiofrequency ablation","volume":"100","author":"Aufranc","year":"2019","journal-title":"Diagn. Interv. Imaging"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13244-019-0727-5","article-title":"Cryoablation and immunotherapy: An overview of evidence on its synergy","volume":"10","author":"Aarts","year":"2019","journal-title":"Insights Imaging"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Yamauchi, Y., Izumi, Y., Hashimoto, K., Yashiro, H., Inoue, M., Nakatsuka, S., Goto, T., Anraku, M., Ohtsuka, T., and Kohno, M. (2012). Percutaneous cryoablation for the treatment of medically in-operable stage I nonsmall cell lung cancer. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033223"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jvir.2016.04.005","article-title":"Percutaneous Cryoablation for the Treatment of Primary and Metastatic Lung Tumors: Identification of Risk Factors for Recurrence and Major Complications","volume":"27","author":"McDevitt","year":"2016","journal-title":"J. Vasc. Int. Radiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.jvir.2010.04.029","article-title":"Temperature isotherms during pulmonary cryoablation and their correlation with the zone of ablation","volume":"21","author":"Hinshaw","year":"2010","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"110873","DOI":"10.1016\/j.apradiso.2023.110873","article-title":"Evaluating the applications and effectiveness of magnetic nanoparticle-based hyperthermia for cancer treatment: A systematic review","volume":"198","author":"Farzanegan","year":"2023","journal-title":"Appl. Radiat. Isot."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"nwaa122","DOI":"10.1093\/nsr\/nwaa122","article-title":"Biodegradable magnesium alloy with eddy thermal effect for effective and accurate magnetic hyperthermia ablation of tumors","volume":"8","author":"Yang","year":"2020","journal-title":"Natl. Sci. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1016\/j.biomaterials.2013.03.061","article-title":"Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy","volume":"34","author":"Sadhukha","year":"2013","journal-title":"Biomaterials"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-5002(03)00152-1","article-title":"The role of radiotherapy in the treatment of stage I non-small cell lung cancer","volume":"41","author":"Qiao","year":"2003","journal-title":"Lung Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/107327480801500202","article-title":"Stereotactic body radiation therapy: Transcending the conventional to improve outcomes","volume":"15","author":"Dilling","year":"2008","journal-title":"Cancer Control."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijrobp.2018.08.027","article-title":"Initial Results of a Multicenter Phase 2 Trial of Stereotactic Ablative Radiation Therapy for Oligometastatic Cancer","volume":"103","author":"Sutera","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1470-2045(18)30896-9","article-title":"Stereotactic ablative radiotherapy versus standard radiotherapy in stage I non small cell lung cancer (TROG 09.02 CHISEL): A phase 3, open label, randomized controlled trial","volume":"20","author":"Ball","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1378\/chest.124.5.1946","article-title":"Extracranial stereotactic radioablation: Result of a phase I study in. medically inoperable stage I non-small cell lung cancer","volume":"124","author":"Timmerman","year":"2003","journal-title":"Chest"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ijrobp.2008.11.042","article-title":"Stereotactic body radiation therapy for early-stage non small-cell lung carcinoma: Four-year results of A prospective phase II study","volume":"75","author":"Fakiris","year":"2009","journal-title":"Int. J. Rad. Oncol. Biol. Phys."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Sterotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ijrobp.2007.10.053","article-title":"Outcomes of risk adapted fractionated stereotactic radiotherapy for stage I non-small cell lung cancer","volume":"70","author":"Lagerwaard","year":"2008","journal-title":"Int. J. Radiat. Biol. Phys."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1002\/cncr.29507","article-title":"Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial","volume":"121","author":"Grasso","year":"2015","journal-title":"Cancer"},{"key":"ref_56","first-page":"1","article-title":"Radiofrequency ablation of stage IA non\u2013small cell lung cancer in patients ineligible for surgery: Results of a prospective multicenter phase II trial","volume":"13","author":"Chomy","year":"2018","journal-title":"J. Cardiothorac. Surg."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.athoracsur.2011.11.043","article-title":"Radiofrequency Ablation for Stage I Non-Small Cell Lung Cancer: Management of Locoregional Recurrence","volume":"93","author":"Lanuti","year":"2012","journal-title":"Ann. Thorac. Surg."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jtcvs.2011.02.036","article-title":"Percutaneous radiofrequency ablation of clinical stage I non\u2013small cell lung cancer","volume":"142","author":"Hiraki","year":"2011","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijsu.2018.03.034","article-title":"Long-term results of CT-guided percutaneous radiofrequency ablation of inoperable patients with stage Ia non-small cell lung cancer: A retrospective cohort study","volume":"53","author":"Huang","year":"2018","journal-title":"Int. J. Surg."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jtcvs.2008.08.034","article-title":"Radiofrequency ablation for treatment of medically inoperable stage I non\u2013small cell lung cancer","volume":"137","author":"Lanuti","year":"2009","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1258\/ar.2012.110333","article-title":"Recurrent non-small cell lung cancer: Evaluation of CT-guided radiofrequency ablation as salvage therapy","volume":"53","author":"Schoellnast","year":"2012","journal-title":"Acta Radiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"124698","DOI":"10.1016\/j.ijheatmasstransfer.2023.124698","article-title":"Modified Pennes bioheat equation with heterogeneous blood perfusion: A newer perspective","volume":"218","author":"Singh","year":"2024","journal-title":"Int. J. Heat Mass Transf."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/24\/5869\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:39:57Z","timestamp":1760132397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/24\/5869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,16]]},"references-count":62,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["cancers15245869"],"URL":"https:\/\/doi.org\/10.3390\/cancers15245869","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,16]]}}}